Homology Medicines has reached its limit for free report views.
Homology Medicines does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Homology Medicines Inc. is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders.
